False Advertising Claims Under the Lanham Act
Section 43(a) of the Lanham Act provides a federal cause of action for false advertising that extends well beyond trademark infringement to reach deceptive commercial speech about products and services. This page covers the statutory definition, the elements a plaintiff must prove, the factual scenarios where these claims most commonly arise, and the boundaries that separate actionable false advertising from mere puffery or non-commercial opinion. Businesses, brand owners, and legal practitioners navigating competitive disputes will find the Lanham Act's false advertising provision among the most powerful and technically demanding tools in commercial litigation.
Definition and scope
The false advertising cause of action is codified at 15 U.S.C. § 1125(a)(1)(B) of the Lanham Act. That provision prohibits any person from using, in commercial advertising or promotion, a false or misleading description or representation of fact that:
The statute applies to both the advertiser's own goods or services and to the goods or services of another — meaning competitors have standing to sue when a rival's advertising contains false claims about the competitor's products. This competitor-standing feature distinguishes the Lanham Act's false advertising provision from consumer protection statutes, which vest enforcement authority primarily in regulatory agencies such as the Federal Trade Commission (FTC).
The scope of "commercial advertising or promotion" under Section 43(a) is narrower than it may appear. Courts applying the standard from Gordon & Breach Science Publishers v. American Institute of Physics, 859 F. Supp. 1521 (S.D.N.Y. 1994), have held that a statement must be: (1) commercial speech; (2) made by a defendant in commercial competition with the plaintiff; (3) for the purpose of influencing consumers to buy the defendant's goods or services; and (4) sufficiently disseminated to constitute advertising or promotion. Isolated private communications, editorial content, and non-commercial speech fall outside this framework. For broader context on the statute's structure, the Lanham Act overview covers the full range of claims available under 15 U.S.C. § 1051 et seq.
How it works
A plaintiff asserting a false advertising claim under Section 43(a)(1)(B) must establish five elements, as consistently applied by federal circuit courts:
- False or misleading statement of fact. The advertisement must contain a statement that is either literally false on its face or literally true but likely to mislead consumers in context.
- Materiality. The false or misleading statement must be material — meaning it is likely to influence a consumer's purchasing decision. Courts have held that claims going directly to the central characteristic of a product are presumptively material.
- Commercial advertising or promotion. The statement must appear in a commercial context disseminated broadly enough to constitute advertising, as defined by the Gordon & Breach factors above.
- Interstate commerce. The conduct must occur in interstate commerce, satisfying the Lanham Act's jurisdictional predicate under 15 U.S.C. § 1127.
- Injury or likelihood of injury. The plaintiff must demonstrate that the false advertising caused or is likely to cause commercial injury — typically lost sales, reputational harm, or diverted consumer demand.
A critical bifurcation governs the proof burden. When a statement is literally false, courts presume consumer deception and the plaintiff need not introduce consumer surveys or market evidence. When a statement is literally true but misleading (implied falsity), the plaintiff bears the burden of demonstrating actual consumer deception, typically through survey evidence showing a statistically significant percentage of consumers drew a false inference.
Remedies available under 15 U.S.C. § 1117 include the defendant's profits, the plaintiff's actual damages, costs of the action, and — in exceptional cases involving willful conduct — attorneys' fees. Injunctive relief under 15 U.S.C. § 1116 is available and frequently sought as the primary remedy, particularly when the false advertising is ongoing.
Common scenarios
False advertising claims under Section 43(a) arise across four recurring factual patterns:
Comparative advertising claims. A company runs advertisements directly comparing its product to a named competitor using false performance data, manipulated test results, or cherry-picked metrics. This is the paradigmatic Lanham Act false advertising case. The advertiser's use of the competitor's name and marks in an advertising context is permissible as nominative fair use, but false factual assertions about either product create liability.
Ingredient and composition claims. A manufacturer advertises that a product contains a specified percentage of a premium ingredient — for example, "100% natural" or "contains X grams of active ingredient per serving" — when testing demonstrates the representation is inaccurate. The FTC and the Food and Drug Administration (FDA) regulate many such claims under separate statutory frameworks, but a competitor may independently pursue a Lanham Act claim without waiting for agency action.
Geographic origin and certification claims. Representations that goods originate from a specific region — such as a wine appellation or agricultural designation — when they do not meet the qualifying criteria implicate Section 43(a)(1)(B). This overlaps with the broader regulatory context for trademark law, including rules administered by the Alcohol and Tobacco Tax and Trade Bureau (TTB) for geographic designations in alcohol products.
Endorsement and clinical study misrepresentation. Advertising that falsely claims a product is endorsed by a professional organization, or that cites a clinical study that does not support the stated conclusion, has repeatedly formed the basis for Lanham Act false advertising suits. The FTC's Guides Concerning the Use of Endorsements and Testimonials in Advertising, 16 C.F.R. Part 255, provide a parallel regulatory framework but do not displace the private right of action under the Lanham Act.
Decision boundaries
Distinguishing actionable false advertising from non-actionable speech requires applying three principal boundary tests.
Puffery versus statement of fact. Vague superlatives and subjective opinions — "the best service in the industry," "unmatched quality" — are classified as puffery and are not actionable under Section 43(a) because no reasonable consumer would treat them as verifiable factual claims. By contrast, statements of specific, measurable attributes — "our product lasts 3 times longer than Brand X" — are statements of fact subject to the falsity analysis.
Commercial speech versus non-commercial speech. Statements appearing in news articles, academic publications, or non-promotional context, even if false, do not constitute "commercial advertising or promotion" under the statute. The First Amendment overlay means that restricting non-commercial speech through the Lanham Act would raise constitutional concerns.
Lanham Act versus state law and FTC claims. The Lanham Act's false advertising provision creates a federal cause of action available only to parties with a direct commercial interest in the relevant market — specifically, competitors. Consumers cannot sue under Section 43(a). State consumer protection statutes (such as California's Unfair Competition Law, Business & Professions Code § 17200, or New York's General Business Law § 349) and FTC enforcement under 15 U.S.C. § 45 provide parallel frameworks with different standing rules and remedies. The false advertising and trademark law resource covers the intersection of these regimes in detail.
The Supreme Court's decision in Lexmark International, Inc. v. Static Control Components, Inc., 572 U.S. 118 (2014), resolved a circuit split by establishing that a plaintiff must fall within the "zone of interests" the Lanham Act protects and must demonstrate a proximate cause relationship between the defendant's misrepresentation and the plaintiff's commercial injury. That standard — not a market-share test or a categorical rule — now governs standing for false advertising plaintiffs in all federal circuits.